Correlation Between Cerevel Therapeutics and Vaxcyte
Can any of the company-specific risk be diversified away by investing in both Cerevel Therapeutics and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cerevel Therapeutics and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cerevel Therapeutics Holdings and Vaxcyte, you can compare the effects of market volatilities on Cerevel Therapeutics and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cerevel Therapeutics with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cerevel Therapeutics and Vaxcyte.
Diversification Opportunities for Cerevel Therapeutics and Vaxcyte
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Cerevel and Vaxcyte is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Cerevel Therapeutics Holdings and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and Cerevel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cerevel Therapeutics Holdings are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of Cerevel Therapeutics i.e., Cerevel Therapeutics and Vaxcyte go up and down completely randomly.
Pair Corralation between Cerevel Therapeutics and Vaxcyte
If you would invest (100.00) in Cerevel Therapeutics Holdings on September 13, 2024 and sell it today you would earn a total of 100.00 from holding Cerevel Therapeutics Holdings or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Cerevel Therapeutics Holdings vs. Vaxcyte
Performance |
Timeline |
Cerevel Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Vaxcyte |
Cerevel Therapeutics and Vaxcyte Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cerevel Therapeutics and Vaxcyte
The main advantage of trading using opposite Cerevel Therapeutics and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cerevel Therapeutics position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.Cerevel Therapeutics vs. Avidity Biosciences | Cerevel Therapeutics vs. Revolution Medicines | Cerevel Therapeutics vs. Day One Biopharmaceuticals | Cerevel Therapeutics vs. SpringWorks Therapeutics |
Vaxcyte vs. Larimar Therapeutics | Vaxcyte vs. Syndax Pharmaceuticals | Vaxcyte vs. Merus BV | Vaxcyte vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |